Breaking News
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
November 17, 2017 - Just-in-time 3-D implants set to transform tumor surgery
November 17, 2017 - Skin patch offers hope for people with peanut allergy
November 17, 2017 - Scientists identify biomarkers that predict risk of death in Ebola patients
November 17, 2017 - Heart attack, stroke patients have improved outcomes when statins are prescribed after discharge
November 17, 2017 - Majority of people do not understand link between obesity and cancer, study shows
November 17, 2017 - Deep vein thrombosis accurately diagnosed by GPs trained in compression ultrasonography
November 17, 2017 - New Kevlar-based hydrogel recreates the magic of natural cartilage
November 17, 2017 - FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence
November 17, 2017 - Foods made with biofortified corn flour and eggs retain vitamin A after cooking
November 17, 2017 - Integrated Care Winning the Day for Healthcare Companies
November 17, 2017 - CPAP may be superior to gastric banding for severe sleep apnea
November 17, 2017 - New pain relievers reduce opiate overdose risk
November 17, 2017 - Brain astrocytes could play key role in pathogenesis of Alzheimer’s disease
November 17, 2017 - Researchers test whether LVAD surgery could reverse frailty in older adults with heart failure
November 17, 2017 - ATS debuts new video to highlight dangers of flavored tobacco
November 17, 2017 - Medicaid expansion under ACA more likely to increase smoking cessation rates among low-income adults
November 17, 2017 - FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII
November 17, 2017 - 1 in 5 Americans Still Uses Tobacco, Gov’t. Reports: MedlinePlus Health News
November 17, 2017 - People with psychotic-like experiences spend less time in healthy brain states
November 17, 2017 - Hospital Readmission Reduction Program linked to increase in death rates, study finds
November 17, 2017 - Study finds rising rates of marijuana use in states where it is legal
November 17, 2017 - Scientists unveil pathology underlying optic nerve hypoplasia in children
November 17, 2017 - Novel device designed to treat diastolic heart failure found safe and effective
November 17, 2017 - Smoking parents may underestimate kid’s exposure to secondhand smoke
November 17, 2017 - FAIMS technology holds potential to be effective screening tool for pancreatic cancer
November 17, 2017 - Applying AFM to study the viscoelastic properties of cells
November 17, 2017 - FDA Alert: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall
November 17, 2017 - High cognitive ability not a safeguard from conspiracies, paranormal beliefs
November 17, 2017 - Computerized speed of processing training results in decreased risk of dementia
November 17, 2017 - Sexual activity poses exceedingly small risk in causing sudden cardiac arrest
UM SOM learn about unearths intriguing courting between sleep, cognition and kynurenine compound

UM SOM learn about unearths intriguing courting between sleep, cognition and kynurenine compound

image_pdfDownload PDFimage_print

Greater than three.2 million American citizens be afflicted by schizophrenia; about 100,000 persons are newly identified once a year. The illness contains quite a lot of signs together with visible and auditory hallucinations, cognitive issues and motivational problems. A key factor with the illness, and one who will get much less consideration than different signs, is cognitive issues. Many with the illness have hassle with finding out and reminiscence. For lots of, that is the primary signal of the illness.

A brand new learn about by means of researchers on the College of Maryland Faculty of Medication (UM SOM) has discovered intriguing hyperlinks between sleep, cognition and a compound known as kynurenine. Those hyperlinks may just remove darkness from the mechanism that reasons cognitive issues amongst the ones with the illness, and may just level how to new therapies to scale back one of the vital illness’s signs.

The findings had been printed these days within the magazine Sleep. The learn about is the primary to remove darkness from intimately the hyperlinks between kynurenine, its metabolite kynurenic acid, sleep and cognition.

“No person has seemed carefully on the courting between sleep and the kynurenine pathway prior to,” mentioned Ana Pocivavsek, a researcher on the UM SOM Maryland Psychiatric Analysis Heart (MPRC) and an assistant professor within the Division of Psychiatry. “This analysis establishes a transparent hyperlink between elevations in kynurenine and sleep issues.”

Lately, scientists have recognized kynurenic acid as a possible key participant in schizophrenia. Kynurenic acid is a neuroactive metabolite of kynurenine this is shaped within the mind. Other people with schizophrenia have upper than standard ranges of kynurenic acid of their brains. Scientists have theorized that those increased ranges could be hooked up with a spread of signs noticed within the illness, together with issues of finding out and reminiscence.

The mechanisms underlying the cognitive impairments in sufferers, on the other hand, have remained unclear. Dr. Pocivavsek and her colleagues suspected that an interaction between increased kynurenic acid and sleep may just play a task. There may be a large number of proof in each people and animals that sleep disorder ends up in issues of finding out and reminiscence. As well as, researchers and clinicians have lengthy famous that folks with schizophrenia steadily have issues of sleep as smartly.

For those experiments, she and her colleagues studied rats. They made comparisons within the habits of rats with greater kynurenic acid of their brains to animals with standard ranges of the compound. They hooked up the animals’ brains to a tool that measured the volume and high quality of sleep, and located that the animals with upper ranges of kynurenic acid had considerably much less speedy eye motion, or REM, sleep. That is the sleep section through which goals happen, and it’s regarded as crucial for the consolidation of earlier finding out.

The researchers discovered that the gang with top kynurenic acid additionally had issues of finding out. To check this, they position rats in a field and shine mild into the field. On one aspect of the field there may be a gap right into a darker house. Rats are nocturnal animals, and like the darkish, so the animals in most cases run to the darkish house. As soon as on this house, they obtain a small electrical surprise. When the experiment is repeated tomorrow, standard animals don’t run to the darker house, remembering the surprise from the day prior to. By way of comparability, animals with greater ranges of top kynurenic acid, and thus impaired sleep, don’t take into account the surprise from the day prior to, and run into the darkish house. In different phrases they didn’t be told from the day gone by’s enjoy.

“What we are beginning to take into consideration is that kynurenic acid disrupts sleep, which then disrupts cognition,” she mentioned. Then again, there are different probabilities, she says: it can be that disruptions in sleep reason greater kynurenic acid, which then ends up in cognitive issues. “It isn’t transparent which occurs first,” she says. “That may be a in point of fact attention-grabbing query, and one who we’re investigating.”

Dr. Pocivavsek and different researchers theorize that lowering kynurenic acid may just scale back issues of sleep and cognition in sufferers with schizophrenia. “We unquestionably imagine that prime ranges of kynurenic acid are a the most important side of schizophrenia,” she says.

The analysis supplies extra reason why to increase medications that scale back kynurenic acid ranges within the mind. One key chance is to inhibit an enzyme known as kynurenine aminotransferase II, or KAT II, which converts kynurenine to kynurenic acid. The use of compounds that inhibit this enzyme, researchers had been in a position to scale back the volume of kynurenic acid within the mind. Over time, quite a lot of pharmaceutical firms have labored to increase inhibitors of KAT II that may achieve the mind, and can be secure and efficient in people. Dr. Pocivavsek’s analysis supplies proof that this way has scientific possible.

“This learn about provides to the proof that prime ranges of kynurenic acid give a contribution to cognitive disorder,” she says. “If we will be able to get a hold of techniques to scale back the ones ranges, we could possibly scale back those signs for sufferers.”


Tagged with:

About author

Related Articles